Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | EVP, Innov & Chem Sciences | February 28, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 339,104 |
Ending reported balance
After 2025-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-02-28 · Exercise / conversion · Acquired 25,667 · Balance 281,391 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 2 · 2025-02-28 · Exercise / conversion · Acquired 32,904 · Balance 314,295 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 3 · 2025-02-28 · Exercise / conversion · Acquired 68,243 · Balance 382,538 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 4 · 2025-02-28 · Tax withholding · Disposed 43,434 · Balance 339,104 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-02-28 · Exercise / conversion · Disposed 25,667 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 32,903 |
Reported balance
After 2025-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-02-28 · Exercise / conversion · Disposed 32,904 · Balance 32,903 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 136,487 |
Reported balance
After 2025-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-02-28 · Exercise / conversion · Disposed 68,243 · Balance 136,487 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 68,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,487 Underlying: Common Stock · 68,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 32,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,903 Underlying: Common Stock · 32,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · derivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 43,434 | $0.67 | $29,100.78 |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,104 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 68,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 32,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 25,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007534 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:21 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 502,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005221 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,060 Underlying: Common Stock · 502,060 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:21 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 753,090 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005221 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753,090 Underlying: Common Stock · 753,090 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 32,903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,807 Underlying: Common Stock · 32,903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,667 Underlying: Common Stock · 25,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · derivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 24,408 | $2.62 | $63,948.96 |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,724 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 32,903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 25,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:30 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007623 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 204,730 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004466 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,730 Underlying: Common Stock · 204,730 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 204,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004466 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,730 Underlying: Common Stock · 204,730 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,333 Underlying: Common Stock · 25,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,976 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,977 Underlying: Common Stock · 8,976 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · derivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 20,946 | $2.17 | $45,452.82 |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,586 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 25,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,976 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007927 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 296,130 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004934 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,130 Underlying: Common Stock · 296,130 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 98,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004934 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,710 Underlying: Common Stock · 98,710 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,953 Underlying: Common Stock · 8,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,300 Underlying: Common Stock · 23,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 22,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · derivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 19,756 | $2.85 | $56,304.60 |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,589 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 22,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007174 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 77,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004767 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 77,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 230,990 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004767 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,990 Underlying: Common Stock · 230,990 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · derivative · entry 9 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 23,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F6 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 22,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · derivative · entry 8 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,373 Underlying: Common Stock · 22,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · derivative · entry 7 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · derivative · entry 6 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,497 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 20,413 | $7.19 | $146,769.47 |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · nonDerivative · entry 5 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,695 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 23,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · nonDerivative · entry 4 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 22,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · nonDerivative · entry 3 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008772 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:14 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 80,780 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001127602-21-005837 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,780 Underlying: Common Stock · 80,780 shares Expires 2031-02-11 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:14 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 26,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005837 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,930 Underlying: Common Stock · 26,930 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,813 | $1.96 | $13,353.48 |
DisclosureSEC source: 0001127602-20-014491 · form4.xml · nonDerivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,640 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 19,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014491 · form4.xml · nonDerivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,453 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 22,373 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008956 · form4.xml · derivative · entry 9 MAIN ALAN J · CIK 0001227372 · EVP, Commercial Supply Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,747 Underlying: Common Stock · 22,373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.